Exploring functional in vivo consequences of the selective genetic ablation of mTOR signaling in T helper lymphocytes

Methods in Molecular Biology

Volumn 821, Issue , 2012, Pages 317-327

  Delgoffe, Greg M ^a   Powell, Jonathan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CD4; mTOR; T cells

Indexed keywords

CYTOKINE; MTOR PROTEIN, HUMAN; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL DIFFERENTIATION; GENE DELETION; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY; MOUSE; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; GENE DELETION; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS; SIROLIMUS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TOR SERINE-THREONINE KINASES;

MAMMALIA;

EID: 84555189464     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-430-8_20     Document Type: Article

References (13)

1. Sabatini, D. M. (2006) mTOR and cancer: insights into a complex relationship, Nat Rev Cancer 6, 729-734. (Pubitemid 44286004)
2. Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., and Powell, J. D. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment, Immunity 30, 832-844.
3. Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., and Ahmed, R. (2009) mTOR regulates memory CD8 T-cell differentiation, Nature 460, 108-112.
4. Rao, R. R., Li, Q., Odunsi, K., and Shrikant, P. A. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin, Immunity 32, 67-78.
5. Kopf, H., de la Rosa, G. M., Howard, O. M., and Chen, X. (2007) Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells, Int Immunopharmacol 7, 1819-1824. (Pubitemid 350046435)
6. Valmori, D., Tosello, V., Souleimanian, N. E., Godefroy, E., Scotto, L., Wang, Y., and Ayyoub, M. (2006) Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells, J Immunol 177, 944-949. (Pubitemid 44036595)
7. Battaglia, M., Stabilini, A., and Roncarolo, M. G. (2005) Rapamycin selectively expands CD4 + CD25 + FoxP3+ regulatory T cells, Blood 105, 4743-4748. (Pubitemid 40807298)
8. Wang, B., Xiao, Z., Chen, B., Han, J., Gao, Y., Zhang, J., Zhao, W., Wang, X., and Dai, J. (2008) Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway, PLoS One 3, e1856.
9. Guertin, D. A., and Sabatini, D. M. (2007) Defining the role of mTOR in cancer, Cancer Cell 12, 9-22. (Pubitemid 47001784)
10. Zheng, Y., Delgoffe, G. M., Meyer, C. F., Chan, W., and Powell, J. D. (2009) Anergic T cells are metabolically anergic, J Immunol 183, 6095-6101.
11. Guertin, D. A., and Sabatini, D. M. (2009) The pharmacology of mTOR inhibition, Sci Signal 2, pe24.
12. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L., and Sabatini, D. M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/ PKB, Mol Cell 22, 159-168.
13. Delgoffe, G. M., and Powell, J. D. (2009) mTOR: taking cues from the immune microenvironment, Immunology 127, 459-465.